Open AccessCost-effectiveness of lenalidomide in combination with dexamethasone compared to bortezomib in combination with dexamethasone for the second-line treatment of multiple myeloma in Chile
Author(s) -
Susana Aceituno,
Irmina Gozalbo,
Marilena Appierto,
Luís Lizán
Publication year - 2018
Publication title -
medwave
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.178
H-Index - 7
ISSN - 0717-6384
DOI - 10.5867/medwave.2018.03.7220
Subject(s) - medicine , lenalidomide , bortezomib , multiple myeloma , dexamethasone , oncology , cost effectiveness , risk analysis (engineering)